Darzalex

198,00 558,00 

Therapeutic CD38-antibody from the original Darzalex commercial drug targeting the CD38-antigen, also referred to as Darzalex antibody.

Category Product Concentration [mg/mL] Volume per Vial [µL] Quantity per vial [mg] Batch Number CoA [see Note 2] Original therapeutic expiry date [see Note 1] PriceQuantityTotal
aliquot 202004GDS0004no09/2017 558,00 
-
+
558,00 
spinner
aliquot 201002GHS0702no01/2018 198,00 
-
+
198,00 
spinner
aliquot 201503GKS0B06no04/2018 238,00 
-
+
238,00 
spinner
aliquot 201002DQF1105no11/2018 198,00 
-
+
198,00 
spinner
aliquot 201002DQF1122no05/2019 198,00 
-
+
198,00 
spinner
aliquot 201002HIS4901no09/2019 396,00 
-
+
396,00 
spinner

Category: SKU: N/A

Description

Additional information

Category

aliquot, dilution

Therapeutic molecule

Daratumumab

Antigen

CD38

Product Concentration [mg/mL]

1, 20

Volume per Vial [µL]

100, 150, 200

Quantity per vial [mg]

0, 0,1, 2, 3, 4

Batch Number

NOT APPLICABLE, DQF1105, DQF1122, HIS4901, GKS0B06, GDS0004, -, GHS0702

CoA [see Note 2]

no

Manufacturing Year

2016, 2017, 2018

Original therapeutic expiry date [see Note 1]

-, 01/2018, 04/2018, 05/2019, 09/2017, 09/2019, 11/2018, NOT APPLICABLE

You may also like…